Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

79.83 +2.13 (+2.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,958,350
Open 76.58
Bid (Size) 79.75 (13)
Ask (Size) 79.88 (3)
Prev. Close 77.70
Today's Range 74.50 - 80.26
52wk Range 62.55 - 217.25
Shares Outstanding 381,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy
Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc (NYSE: PFE), alleging the pharmaceutical giant misrepresented the efficacy of its widely- 
Via Benzinga
Topics Lawsuit
Exposures COVID-19 Financial Legal
Texas Sues Pfizer For "Misrepresenting COVID-19 Vaccine Efficacy" And "Conspiring To Censor Public Discourse"
The Texas attorney general is suing pharmaceutical giant Pfizer for misrepresenting the effectiveness of the company's Covid-19 
Via Talk Markets
Topics Lawsuit
Exposures COVID-19 Financial Legal

Performance

YTD
-55.40%
-55.40%
1 Month
+4.76%
+4.76%
3 Month
-29.08%
-29.08%
6 Month
-38.83%
-38.83%
1 Year
-56.01%
-56.01%

More News

Read More
Analyst Expectations for Moderna's Future
Via Benzinga
Upwork underscores the strength of the AI gig economy
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024.
Via InvestorPlace
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Big Players' Recent Trades in MRNA Options
Via Benzinga
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
Via Benzinga
Topics Stocks
Exposures US Equities
3 Biotech Stocks That Could Be Millionaire Makers
Via The Motley Fool
Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Big Players' Recent Trades in MRNA Options
Via Benzinga
Peering Into Moderna's Recent Short Interest
Via Benzinga
Don’t Let the Q3 Earnings Miss Keep You From These 3 Stocks!
Via InvestorPlace
Topics Earnings Stocks
Exposures Financial US Equities
Moderna to Host Second Environmental, Social and Governance (ESG) Investor Event on December 7th, 2023
Via ACCESSWIRE
3 Cathie Wood Bargain Buys That Should Be on Your List Too
Via The Motley Fool
Where Will Novavax Be in 3 Years?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Top Biotech Stocks to Buy Right Now
Via The Motley Fool
Moderna to Present at Upcoming Conferences in November 2023
Via ACCESSWIRE
Moderna Unusual Options Activity For November 08
Via Benzinga
Moderna Highlights its Digital and AI Strategy and Progress at Second Digital Investor Event
Via ACCESSWIRE
Why Moderna Stock Was Cratering This Week
Via The Motley Fool
Exposures COVID-19
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
Via The Motley Fool
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.